Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis

Evaluates shortened treatment regimens, versus standard six-month treatment regimen, in individuals with drug-sensitive pulmonary TB

From:
Department for International Development
Published
12 January 2018
Document Type:
Journal Article
Theme:
Health
Authors:
Grace, A.G., Mittal, A, Jain, S, Tripathy, J.P.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy and safety of shortened treatment regimens, versus the standard six-month treatment regimen, in individuals with drug-sensitive pulmonary tuberculosis.

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Grace AG, Mittal A, Jain S, Tripathy JP, Satyanarayana S, Tharyan P, Kirubakaran R. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis. Cochrane Database Systematic Review. 2018;(1):CD012918.

Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis

Updates to this page

Published 12 January 2018
Contents